Long term Results of a Phase I/ Ib Study of Ibrutinib in Combination with Umbralisib in Patients with Relapsed/Refractory CLL or MCL

Drug Category: Array
Conference Category: Array
Lead Author: Davids M, et al.
Published Date: 12/06/2020
Download Link: /wp-content/uploads/2020/06/Final-EHA-Umbra-Ibrutinib-RR-CLL-NMCL-Davids.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top